Quality for All: Clinical Trial Enrollment and End‐of‐Life Care in Solid and Hematologic Malignancies
Enrollment in clinical trials in the last YOL was associated with metrics of aggressive EOL care, with low rates of GOC documentation to determine if this care is goal-concordant. Low rates of palliative care and hospice engagement across the study population suggest opportunities for improvement for all patients, regardless of trial enrollment.
Authors
- Melissa Rosen (ORCID: https://orcid.org/0000-0001-7641-9690)
- Brittany Anne Davidson (ORCID: https://orcid.org/0000-0001-9698-0442)
- Tracy Truong (ORCID: https://orcid.org/0000-0001-5923-4037)
- Thomas W. LeBlanc (ORCID: https://orcid.org/0000-0002-0546-7895)
- Laura Jean Havrilesky (ORCID: https://orcid.org/0000-0002-4259-5992)
- Christine Gervais (ORCID: https://orcid.org/0000-0001-5695-9358)
Institutions
- Johns Hopkins University (US)
- Duke University (US)
- Duke Medical Center (US)
Publication Details
- Journal
- Cancer Medicine
- Published
- 2025-04-27
- DOI
- https://doi.org/10.1002/cam4.70775
- Primary Topic
- Palliative Care and End-of-Life Issues
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- National Institutes of Health
- National Center for Advancing Translational Sciences